相关实验视频
Updated: Jul 19, 2025

07:49
Colonial Wig Pancreaticojejunostomy
Published on: March 12, 2019
12.1K
胃穿孔引起的一般性闭塞/类似闭塞综合征和稳定的胃甲BPC 157治疗效果
Luka Kalogjera1, Ivan Krezic1, Ivan Maria Smoday1
1Department of Pharmacology, School of Medicine, Zagreb 10000, Croatia.
World journal of gastroenterology
|August 7, 2023
概括
在老鼠的胃穿孔导致严重的闭塞综合征,导致血管和多器官衰竭. 稳定的胃甲BPC 157有效抵消了这种综合征,证明了治疗潜力.
科学领域:
- 胃肠病学 胃肠病学
- 血管生物学 血管生物学
- 再生医学是一种再生医学.
背景情况:
- 在老鼠的胃穿孔作为研究细胞保护的模型.
- 这种穿孔会引起严重的闭塞/类似闭塞的综合征,其特征是血管和多器官衰竭.
- 稳定的胃甲BPC 157在解决类似综合征方面表现有前途.
研究的目的:
- 为了研究胃孔穿孔诱导的闭塞/闭塞状综合征.
- 评估稳定的胃甲BPC 157对这种综合征的治疗作用.
主要方法:
- 在麻醉和腹腔切除术后,老鼠经历了胃孔穿孔,以诱导闭塞/类似闭塞的综合征.
- 用BPC 157或盐水治疗直接注入穿孔的胃缺陷.
- 评估包括大脑胀,血压,血栓形成,器官损伤和出血时间.
主要成果:
- BPC 157疗法促进了穿孔缺陷的愈合,减少了出血并导致胃收缩.
- BPC 157减弱的头内,门口和马的高血压,以及大动脉的低血压.
- 血栓形成和严重的器官损伤 (大脑,心脏,肺,肝脏,脏) 被BPC 157显著减少.
结论:
- 胃穿孔会导致严重的全身闭塞/类似闭塞的综合征.
- 稳定的胃甲BPC 157迅速抵消这种综合征,在外围和中心.
- 对于这种情况,需要对BPC 157治疗进行进一步的研究.
相关概念视频
Peptic Ulcer Disease V: Surgical Management and Nursing Care
338
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
338
Peptic Ulcer Disease IV: Management
110
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
110
Esophageal Perforation-II: Clinical Manifestations and Management
88
Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
Clinical Manifestations:
88
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
497
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
497
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
454
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
454
Gastritis III: Clinical Manifestations and Management
326
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
326
